e-learning
resources
Virtual 2020
Pre-Congress Content
Novel molecular markers and targets for asthma phenotypes
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Airway gene expression identifies subtypes of Type 2 inflammation in severe asthma
L. Frøssing (Copenhagen, Denmark), A. Silberbrandt (Copenhagen, Denmark), A. Von Bülow (Copenhagen, Denmark), D. Kjærsgaard Klein (Copenhagen, Denmark), M. Ross Christensen (Copenhagen, Denmark), V. Backer (Copenhagen, Denmark), K. Baines (Newcastle, Australia)
Source:
Virtual Congress 2020 – Novel molecular markers and targets for asthma phenotypes
Session:
Novel molecular markers and targets for asthma phenotypes
Session type:
E-poster session
Number:
611
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Frøssing (Copenhagen, Denmark), A. Silberbrandt (Copenhagen, Denmark), A. Von Bülow (Copenhagen, Denmark), D. Kjærsgaard Klein (Copenhagen, Denmark), M. Ross Christensen (Copenhagen, Denmark), V. Backer (Copenhagen, Denmark), K. Baines (Newcastle, Australia). Airway gene expression identifies subtypes of Type 2 inflammation in severe asthma. 611
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Expression of type 1 and type 2 cytokines in central airways of smokers with chronic bronchitis
Source: Eur Respir J 2001; 18: Suppl. 33, 74s
Year: 2001
Variation in the TLR4 gene and airway inflammation among patients with COPD
Source: Annual Congress 2009 - Genetics in the smokers corner: from inflammation in smokers via COPD to cancer
Year: 2009
Characterisation and mRNA expression analysis of the bronchial hyperresponsiveness susceptibility gene protocadherin-1 in asthma patients
Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases
Year: 2009
Gene expression signatures in airway and nasal epithelium of COPD: linking endotypes to clinical outcomes
Source: International Congress 2017 – Heterogeneity in COPD inflammation: implications for therapy and clinical outcomes
Year: 2017
Induced sputum in asthma and COPD: meassuring type and inflammation activity
Source: Eur Respir J 2003; 22: Suppl. 45, 76s
Year: 2003
Airway epithelial toll-like receptor expression in asthma and its relationship to disease severity
Source: Annual Congress 2011 - Immunology and cell biology of asthma and COPD
Year: 2011
The bronchial expression of vanin in moderate to severe asthma
Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets
Year: 2019
Expression of nasal and bronchial IL-17F and related cytokines in frequent exacerbators with neutrophilic severe asthma
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Late Breaking Abstract - Type 2 biomarker expression (FeNO and blood eosinophils) is higher in severe adult-onset than in severe early-onset asthma
Source: Virtual Congress 2021 – Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD
Year: 2021
Human bronchial epithelial cells from patients with asthma have an altered gene expression profile
Source: ERJ Open Res, 8 (1) 00625-2021; 10.1183/23120541.00625-2021
Year: 2022
Chronic persistence of human ?-herpesviruses and regulatory cells phenotypes in severe bronchial asthma.
Source: International Congress 2017 – "Alarming" immunological patterns in asthma
Year: 2017
Distinct epithelial phenotypes in child allergic respiratory disease are revealed by gene expression profiling
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009
Bronchial epithelial gene expression of NOX isoforms are related to important clinical characteristics in COPD
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Differential bronchial epithelial gene expression in COPD versus controls
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016
Expression of the β2-adrenoreceptor and M3-cholinoreceptor genes in patients with different severity of asthma and BHR level
Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma
Year: 2012
Evidence of early abnormal airways’ inflammation in children with type 1 diabetes
Source: Virtual Congress 2021 – Paediatric allergic asthma: novel therapeutics and monitoring approaches
Year: 2021
Cell type specific heat-shock-protein responses to bronchial thermoplasty in severe asthma treatment
Source: International Congress 2018 – New modalities in asthma treatment
Year: 2018
Sputum cell mRNA transcripts demonstrate alteration of endothelin metabolism in severe asthma and COPD
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013
Meta-analysis of airway epithelium gene expression in asthma
Source: Eur Respir J, 51 (5) 1701962; 10.1183/13993003.01962-2017
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept